Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrotide for OHSS prevention
NCT02823080Phase 3Unknown
- Sponsor
- Benha University
- Start
- Oct 2014
- Primary completion
- Apr 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetrorelix in ovarian hyperstimulation syndrome (OHSS), sponsored by Benha University. Status: unknown.
02
Drugs
cetrorelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02823080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823080.